Results 41 to 50 of about 27,643 (258)

Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations

European Journal of Health Economics, 2021
Uncontrolled hyperphosphatemia in chronic kidney disease (CKD) patients commonly results in vascular calcification leading to increased risk of cardiovascular disease. Phosphate binders (PBs) are used for hyperphosphatemia and can be calcium-based (CBPBs)
Kamolpat Chaiyakittisopon, O. Pattanaprateep, Narisa Ruenroengbun, Tunlanut Sapankaew, A. Ingsathit, G. Mckay, J. Attia, A. Thakkinstian   +7 more
semanticscholar   +1 more source

Activation of the Calcium Receptor by Calcimimetic Agents Is Preserved Despite Modest Attenuating Effects of Hyperphosphatemia

Journal of the American Society of Nephrology, 2021
Significance Statement Hyperphosphatemia may contribute to secondary hyperparathyroidism among patients with CKD, but the mechanism responsible remains uncertain.
W. Goodman, D. Ward, K. Martin, Debra K Drayer, Carol Moore, Jiahong Xu, J. Lai, Y. Chon, E. Nemeth   +8 more
semanticscholar   +1 more source

Hyperphosphatemia is a complication of reduced kidney functions and limit for renoprotection

Počki, 2020
Hyperphosphatemia in patients with chronic kidney disease (CKD) is an important complication of impaired renal function and is associated with negative clinical consequences such as cardiovascular calcification, bone disease and secondary ...
S.V. Kushnirenko
doaj   +1 more source

Psödohipoparatiroidi Tip 2: Olgu Sunumu

Genel Tıp Dergisi, 2021
Psödohipoparatiroidi, parathormona karşı hedef organ düzeyinde cevapsızlık nedeniyle hipokalsemi ve hiperfosfatemi gelişmesiyle karakterize bir bozukluktur.
Özlem Güleç Şen, Emre Kaçar, Tolga Altuğ Şen   +2 more
doaj   +1 more source

Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies [PDF]

, 2018
Hyperphosphatemic familial tumoral calcinosis (HFTC)/hyperostosis-hyperphosphatemia syndrome (HHS) is an autosomal recessive disorder of ectopic calcification due to deficiency of or resistance to intact fibroblast growth factor 23 (iFGF23). Inactivating
Burbelo, Christopher J. Romero, Daniela Egli-Spichtig, Emily Farrow, Farzana Perwad, Ichikawa, Lori C. Guthrie, Mary Scott Roberts, Michael J. Econs, Michael T. Collins, Peter D. Burbelo, Rachel I. Gafni, Shimada, Shoji Ichikawa, Uchida   +14 more
core   +1 more source

Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm.

Journal of renal nutrition, 2020
Bone and mineral metabolism becomes dysregulated with progression of chronic kidney disease (CKD), and increasing levels of parathyroid hormone serve as an adaptive response to maintain normal phosphorus and calcium levels.
A. Rastogi, Nisha Bhatt, S. Rossetti, J. Beto   +3 more
semanticscholar   +1 more source

Adverse effects of simulated hyper- and hypo-phosphatemia on endothelial cell function and viability. [PDF]

PLoS ONE, 2011
Dysregulation of phosphate homeostasis as occurs in chronic kidney disease is associated with cardiovascular complications. It has been suggested that both hyperphosphatemia and hypophosphatemia can cause cardiovascular disease.
Ai Peng, Tianfu Wu, Caihong Zeng, Dinesh Rakheja, Jiankun Zhu, Ting Ye, Jack Hutcheson, Nosratola D Vaziri, Zhihong Liu, Chandra Mohan, Xin J Zhou   +10 more
doaj   +1 more source

Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial

Kidney International Reports, 2022
Introduction: Simplified, but effective, hyperphosphatemia treatments with novel mechanisms of action, tolerable safety profiles, and low pill burden are needed for patients undergoing hemodialysis.
Masaaki Inaba, Yotaro Une, Kazuaki Ikejiri, Hironori Kanda, Masafumi Fukagawa, Tadao Akizawa   +5 more
doaj   +1 more source

An Unusual Combination of Neurological Manifestations and Sudden Vision Loss in a Child with Familial Hyperphosphatemic Tumoral Calcinosis [PDF]

, 2019
Hyperphosphatemia in the absence of renal failure is an unusual occurrence, particularly in children, but is a common primary feature of familial hyperphosphatemic tumor calcinosis.
Acton, Dena, Evans, Michael J., Gray, Amie K., Ichikawa, Shoji, Kekunnaya, Ramesh, Lingappa, Lokesh, Madarasu, Rajsekara Chakravarthi, Siddaiahagari, Sirisharani   +7 more
core   +1 more source

Evaluation of a Phosphate Management Protocol to Achieve Optimum Serum Phosphate Levels in Hemodialysis Patients [PDF]

, 2008
Original article can be found at: http://www.sciencedirect.com/science/journal/10512276 Copyright National Kidney Foundation, Inc. DOI: 10.1053/j.jrn.2008.05.003To evaluate the effectiveness of a protocol designed to optimize serum phosphate levels in ...
Cheung, C.F., Cunningham, J., Fan, S., Glass, G., Madden, A.M., Yokum, D.   +5 more
core   +1 more source